FIELD: chemistry.
SUBSTANCE: invention relates to correctors of cytostatic polychemotherapy. As corrector claimed is use of betulonic acid β-alanylamide of formula (I): which potentiates anti-tumor effect and antimetastatic activity of polychemotherapy (PCT), demonstrates antioxidative and cytoprotecting activity at background of tumor PCT, and also produces anti-toxic impact when complex of cytostatic medications is introduced into organism. Compound (I) is synthesised from plant betulin truterpenoid.
EFFECT: obtaining corrector of cytostatic polychemotherapy.
1 cl, 9 ex, 12 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR CORRECTION OF CYTOSTATIC POLYCHEMOTHERAPY WITH ANTI-INFLAMMATORY ACTIVITY | 2010 |
|
RU2425680C1 |
CORRECTIVE AGENT FOR PARANEOPLASTIC DAMAGES AND TOXIC EFFECTS OF CYTOSTATIC POLYCHEMOTHERAPY | 2008 |
|
RU2385324C1 |
N-[3-OXO-LUPANO-28-YL]-PIPERIDINE - AGENT HAVING ANTI-TUMOUR, ANTI-METASTATIC, ANTI-INFLAMMATORY AND CYTOPROTECTIVE ACTIVITY | 2011 |
|
RU2466136C1 |
N-[3-OXO-LUPANO-28-YL]-MORPHOLINE - AGENT FOR CORRECTION OF CYTOTOXIC LIVER DAMAGES WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY | 2011 |
|
RU2461563C1 |
AGENT FOR CORRECTING CYTOTOXIC EFFECTS OF PARANEOPLASTIC PROCESSES AND CHEMOTHERAPY SHOWING ANTICANCER ACTIVITY | 2011 |
|
RU2447888C1 |
AGENT FOR TREATING OSTEOMYELITIS | 2015 |
|
RU2604124C1 |
ANTI-INFLAMMATORY MEDICATION WITH ANTICOAGULANT, ANTITUMOUR AND ANTIMETASTETIC ACTIVITY | 2009 |
|
RU2412712C1 |
N,N'((ALKANDIYL)BIS[LABDA-7(9),13,14-TRIENE-4-CARBOXAMIDES] WITH ANTITUMOUR ACTIVITY | 2017 |
|
RU2654201C1 |
MEANS FOR CHRONIC ATROPHIC GASTRITIS TREATMENT | 2016 |
|
RU2623866C1 |
METHOD FOR ENHANCING OF CYCLOPHOSPHAN ANTITUMOR AND ANTIMETASTATIC ACTIVITY IN EXPERIMENT | 2004 |
|
RU2270682C2 |
Authors
Dates
2009-04-27—Published
2007-09-17—Filed